Inozyme Pharma, Inc. (INZY) Financials

INZY Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 200.8 million 60.4 million
2023-09-30 205.7 million 45.5 million
2023-06-30 150.9 million 45.3 million
2023-03-31 141.8 million 38.4 million

INZY Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -18.6 million 1.7 million
2023-09-30 -18.9 million 1.7 million
2023-06-30 -15.6 million 1.6 million
2023-03-31 -17.9 million 2.1 million

INZY Net Income

No data available :(

INZY Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 188.6 million - 1.8 million
2023-09-30 192.4 million - 2.0 million
2023-06-30 140.2 million 31.9 million 2.2 million
2023-03-31 130.9 million 24.2 million 2.4 million

INZY Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 61.8 million
2023-09-30 56.8 million
2023-06-30 44.9 million
2023-03-31 43.7 million

INZY Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 105000 17.8 million 4.8 million 130000
2023-09-30 7000 13.3 million 4.7 million -
2023-06-30 11000 11.7 million 4.7 million -
2023-03-31 175000 11.9 million 6.5 million -

INZY Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 306000
2023-09-30 - 333000
2023-06-30 - 331000
2023-03-31 - 324000

INZY

Price: $4.87

52 week price:
2.69
7.80

Earnings Per Share: -1.37 USD

P/E Ratio: -3.69

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 94105

Market Capitalization: 396.0 million

Links: